| F 00.01 | Nature of Report (FINREP) | 2×1 | 2 cells |
| F 01.01 | Balance Sheet Statement [Statement of Financial Position]: Assets | 61×1 | 61 cells |
| F 01.02 | Balance Sheet Statement [Statement of Financial Position]: Liabilities | 42×1 | 42 cells |
| F 01.03 | Balance Sheet Statement [Statement of Financial Position]: Equity | 52×1 | 52 cells |
| F 02.00 | Statement of profit or loss | 83×1 | 83 cells |
| F 03.00 | Statement of comprehensive income | 45×1 | 45 cells |
| F 04.01 | Breakdown of financial assets by instrument and by counterparty sector: financial assets held for trading | 19×1 | 19 cells |
| F 04.02.1 | Breakdown of financial assets by instrument and by counterparty sector: non-trading financial assets mandatorily at fair value through profit or loss | 18×2 | 32 cells |
| F 04.02.2 | Breakdown of financial assets by instrument and by counterparty sector: financial assets designated at fair value through profit or loss | 19×2 | 33 cells |
| F 04.03.1 | Breakdown of financial assets by instrument and by counterparty sector: financial assets at fair value through other comprehensive income | 19×14 | 184 cells |
| F 04.04.1 | Breakdown of financial assets by instrument and by counterparty sector: financial assets at amortised cost | 15×14 | 180 cells |
| F 04.05 | Subordinated financial assets | 3×1 | 3 cells |
| F 04.06 | Breakdown of financial assets by instrument and by counterparty sector: trading financial assets | 20×1 | 20 cells |
| F 04.07 | Breakdown of financial assets by instrument and by counterparty sector: non-trading non-derivative financial assets measured at fair value through profit or loss | 19×2 | 33 cells |
| F 04.08 | Breakdown of financial assets by instrument and by counterparty sector: non-trading non-derivative financial assets measured at fair value to equity | 20×13 | 195 cells |
| F 04.09 | Breakdown of financial assets by instrument and by counterparty sector: non-trading non-derivative financial assets measured at a cost-based method | 20×14 | 245 cells |
| F 04.10 | Breakdown of financial assets by instrument and by counterparty sector: other non-trading non-derivative financial assets | 20×14 | 245 cells |
| F 05.01 | Breakdown of non-trading loans and advances by product: Loans and advances other than held for trading, trading or held for sale assets by product | 17×8 | 75 cells |
| F 06.01 | Breakdown of loans and advances other than held for trading, trading or held for sale assets to non-financial corporations by NACE codes | 20×7 | 120 cells |
| F 07.01 | Financial assets subject to impairment that are past due | 27×17 | 312 cells |
| F 07.02 | Financial assets subject to impairment that are past due under national GAAP | 27×8 | 156 cells |
| F 08.01 | Breakdown of financial liabilities by product and by counterparty sector | 46×8 | 221 cells |
| F 08.02 | Subordinated liabilities | 3×4 | 9 cells |
| F 09.01 | Off-balance sheet exposures under national GAAP: Loan commitments, financial guarantees and other commitments given | 24×2 | 48 cells |
| F 09.01.1 | Off-balance sheet exposures : Loan commitments, financial guarantees and other commitments given | 24×16 | 249 cells |
| F 09.02 | Loan commitments, financial guarantees and other commitments received | 21×2 | 21 cells |
| F 10.00 | Derivatives: Trading and economic hedges | 33×11 | 248 cells |
| F 11.01 | Derivatives - Hedge accounting: Breakdown by type of risk and type of hedge | 53×6 | 197 cells |
| F 11.02 | Derivatives - Hedge accounting under National GAAP: Breakdown by type of risk | 32×13 | 302 cells |
| F 11.03 | Non-derivative hedging instruments: Breakdown by accounting portfolio and type of hedge | 8×4 | 22 cells |
| F 11.03.1 | Non-derivative hedging instruments under national GAAP: breakdown by accounting portfolio | 8×1 | 8 cells |
| F 11.04 | Hedged items in fair value hedges | 23×9 | 51 cells |
| F 12.00 | Movements in allowances for credit losses and impairment of equity instruments under national GAAP | 25×10 | 229 cells |
| F 12.01 | Movements in allowances and provisions for credit losses | 75×12 | 868 cells |
| F 12.02 | Transfers between impairment stages (gross basis presentation) | 15×10 | 90 cells |
| F 13.01 | Breakdown of collateral and guarantees by loans and advances other than held for trading | 10×11 | 72 cells |
| F 13.02.1 | Collateral obtained by taking possession during the period (held at the reference date) | 8×7 | 38 cells |
| F 13.03.1 | Collateral obtained by taking possession accumulated | 8×7 | 38 cells |
| F 14.00 | Fair value hierarchy: financial instruments at fair value | 50×11 | 373 cells |
| F 15.00 | Financial assets pledged as collateral: derecognition and financial liabilities associated with transferred financial assets | 40×15 | 332 cells |
| F 16.01 | Breakdown of selected statement of profit or loss items: Interest income and expenses by instrument and counterparty sector(a) | 32×3 | 64 cells |
| F 16.02 | Breakdown of selected statement of profit or loss items: Gains or losses on derecognition of financial assets and liabilities not measured at fair value through profit or loss by instrument | 7×1 | 7 cells |
| F 16.03 | Breakdown of selected statement of profit or loss items: Gains or losses on financial assets and liabilities held for trading and trading financial assets and trading financial liabilities by instrument | 20×1 | 20 cells |
| F 16.04 | Breakdown of selected statement of profit or loss items: Gains or losses on financial assets and liabilities held for trading and trading financial assets and trading financial liabilities by risk | 14×1 | 14 cells |
| F 16.04.1 | Breakdown of selected statement of profit or loss items: Gains or losses on non-trading financial assets mandatorily at fair value through profit or loss by instrument | 5×1 | 5 cells |
| F 16.05 | Breakdown of selected statement of profit or loss items: Gains or losses on financial assets and liabilities designated at fair value through profit or loss by instrument | 16×2 | 26 cells |
| F 16.06 | Breakdown of selected statement of profit or loss items: Gains and losses from hedge accounting | 5×1 | 5 cells |
| F 16.07 | Impairment on financial and non-financial assets | 11×4 | 32 cells |
| F 16.08 | Breakdown of selected statement of profit or loss items: Other administrative expenses | 12×2 | 12 cells |
| F 17.01 | Reconciliation between IFRS and CRR scope of consolidation: Assets | 60×1 | 60 cells |
| F 17.02 | Reconciliation between IFRS and CRR scope of consolidation: Off-balance sheet exposures - loan commitments, financial guarantees and other commitments given | 4×1 | 4 cells |
| F 17.03 | Reconciliation between IFRS and CRR scope of consolidation: Liabilities | 52×1 | 52 cells |
| F 18.00 | (NPE) Information on performing and non-performing exposures | 79×43 | 2573 cells |
| F 18.01 | Inflows and outflows of non-performing exposures - loans and advances by counterparty sector | 15×3 | 30 cells |
| F 18.02 | Commercial Real Estate (CRE) loans and additional information on loans secured by immovable property | 12×36 | 340 cells |
| F 19.00 | Information on forborne exposures | 58×22 | 1124 cells |
| F 20.01 | Geographical breakdown of assets by location of the activities | 55×3 | 110 cells |
| F 20.02 | Geographical breakdown of liabilities by location of the activities | 33×3 | 66 cells |
| F 20.03 | Geographical breakdown of main income statement items by location of the activities | 37×3 | 74 cells |
| F 20.04 | Geographical breakdown of assets by residence of the counterparty | 25×8 | 164 cells |
| F 20.05 | Geographical breakdown of off-balance sheet exposures by residence of the counterparty | 3×5 | 13 cells |
| F 20.06 | Geographical breakdown of liabilities by residence of the counterparty | 13×1 | 13 cells |
| F 20.07.1 | Geographical breakdown by residence of the counterparty of loans and advances other than held for trading to non-financial corporations by NACE codes | 20×6 | 100 cells |
| F 21.00 | Tangible and intangible assets: assets subject to operating lease | 9×1 | 9 cells |
| F 22.01 | Fee and commission income and expenses by activity | 48×1 | 48 cells |
| F 22.02 | Assets involved in the services provided | 16×1 | 16 cells |
| F 23.01 | Loans and advances: Number of instruments | 21×17 | 315 cells |
| F 23.02 | Loans and advances: Additional information on gross carrying amounts | 41×17 | 606 cells |
| F 23.03 | Loans and advances collateralised by immovable property: Breakdown by LTV ratios | 20×17 | 207 cells |
| F 23.04 | Loans and advances: Additional information on accumulated impairments and accumulated negative changes in fair value due to credit risk | 20×17 | 340 cells |
| F 23.05 | Loans and advances: Collateral received and financial guarantees received | 23×17 | 369 cells |
| F 23.06 | Loans and advances: Accumulated partial write-offs | 7×17 | 119 cells |
| F 24.01 | Loans and advances: Inflows and outflows of non-performing exposures | 32×8 | 224 cells |
| F 24.02 | Loans and advances: Flow of impairments and accumulated negative changes in fair value due to credit risk on non-performing exposures | 7×8 | 49 cells |
| F 24.03 | Loans and advances: Write-offs of non-performing exposures during the period | 2×8 | 14 cells |
| F 25.01 | Collateral obtained by taking possession other than collateral classified as Property Plant and Equipment (PP&E): Inflows and outflows | 12×19 | 78 cells |
| F 25.02 | Collateral obtained by taking possession other than collateral classified as Property Plant and Equipment (PP&E): Type of collateral obtained | 12×23 | 181 cells |
| F 25.03 | Collateral obtained by taking possession classified as Property Plant and Equipment (PP&E) | 2×7 | 9 cells |
| F 26.00 | Forbearance management and quality of forbearance | 14×9 | 114 cells |
| F 30.01 | Interests in unconsolidated structured entities | 1×7 | 7 cells |
| F 30.02 | Breakdown of interests in unconsolidated structured entities by nature of the activities | 13×4 | 39 cells |
| F 31.01 | Related parties: amounts payable to and amounts receivable from | 14×6 | 70 cells |
| F 31.02 | Related parties: expenses and income generated by transactions with | 9×6 | 45 cells |
| F 40.01 | Scope of the group: “entity-by-entity” | 0×21 | 19 cells |
| F 40.02 | Scope of the group: "instrument-by-instrument" | 0×12 | 5 cells |
| F 41.01 | Fair value hierarchy: financial instruments at amortised cost | 21×5 | 76 cells |
| F 41.02 | Use of the Fair Value Option | 9×5 | 22 cells |
| F 42.00 | Tangible and intangible assets: carrying amount by measurement method | 11×2 | 22 cells |
| F 43.00 | Provisions | 7×8 | 49 cells |
| F 44.01 | Components of net defined benefit plan assets and liabilities | 11×1 | 11 cells |
| F 44.02 | Movements in defined benefit plans and employee benefits | 12×1 | 12 cells |
| F 44.03 | Staff expenses by type of benefits | 7×1 | 7 cells |
| F 44.04 | Staff expenses by category of remuneration and category of staff | 5×5 | 20 cells |
| F 45.01 | Gains and losses on financial assets and liabilities designated at fair value through profit or loss by accounting portfolio | 3×2 | 4 cells |
| F 45.02 | Gains or losses on derecognition of non-financial assets | 5×1 | 5 cells |
| F 45.03 | Other operating income and expenses | 5×2 | 10 cells |
| F 46.00 | Statement of changes in equity | 21×17 | 224 cells |
| F 47.00 | Loans and advances: Average duration and recovery periods | 4×7 | 28 cells |